Myrmecia pilosula (Jack Jumper) ant venom: Validation of a procedure to standardise an allergy vaccine

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 1, 2008, Pages 58-65

  Wiese, Michael D ^a,b,c   Milne, Robert W ^b   Davies, Noel W ^c   Chataway, Tim K ^d   Brown, Simon G A ^a,e   Heddle, Robert J ^d,f  

^a ROYAL HOBART HOSPITAL   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Allergen standardisation; Enzyme linked immunosorbent assay; Immunoblot; Jack Jumper ant venom; Myrmecia pilosula; Polyacrylamide gel electrophoresis; Reversed phase chromatography

Indexed keywords

ALLERGEN; ALLERGY VACCINE; ANT VENOM; MYR P 1; MYR P 2; MYR P 3; UNCLASSIFIED DRUG; VACCINE;

ANALYTIC METHOD; ANAPHYLAXIS; ANT; ARTICLE; DRUG DESIGN; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; INSECT STING; MYRMECIA PILOSULA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONTENT; STANDARDIZATION; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

ALLERGENS; ANIMALS; ANT VENOMS; ANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESENSITIZATION, IMMUNOLOGIC; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERSENSITIVITY; IMMUNOBLOTTING; INSECT PROTEINS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; VACCINATION; VACCINES;

EID: 36749035279     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.08.028     Document Type: Article

References (21)

1. Brown S.G., Franks R.W., Baldo B.A., and Heddle R.J. J. Allergy Clin. Immunol. 111 (2003) 187-192
2. Douglas R.G., Weiner J.M., Abramson M.J., and O'Hehir R.E. J. Allergy Clin. Immunol. 101 (1998) 129-131
3. Street M.D., Donovan G.R., Baldo B.A., and Sutherland S. Clin. Exp. Allergy 24 (1994) 590-597
4. Brown S.G., Wiese M.D., Blackman K.E., and Heddle R.J. Lancet 361 (2003) 1001-1006
5. Davies N.W., Wiese M.D., and Brown S.G. Toxicon 43 (2004) 173-183
6. Wiese M.D., Chataway T.K., Davies N.W., Milne R.W., Brown S.G., Gai W.P., et al. Toxicon 47 (2006) 208-217
7. Donovan G.R., Baldo B.A., and Sutherland S. Biochim. Biophys. Acta 1171 (1993) 272-280
8. Street M.D., Donovan G.R., and Baldo B.A. Biochim. Biophys. Acta 1305 (1996) 87-97
9. Inagaki H., Akagi M., Imai H.T., Taylor R.W., and Kubo T. Arch. Biochem. Biophys. 428 (2004) 170-178
10. King T.P., Hoffman D., Lowenstein H., Marsh D.G., Platts-Mills T.A., and Thomas W. Allergy 50 (1995) 765-774
11. Wiese M.D., Brown S.G., Chataway T.K., Davies N.W., Milne R.W., Aulfrey S.J., et al. Allergy 62 (2007) 437-443
12. Council of Europe, European Pharmacopoeia, in: European Treaty Series 50, Council of Europe, Strasbourg, 2004, pp. 79-80.
13. Allergy 61 Suppl. 82 (2006) 3-5
14. Platts-Mills T.A., and Chapman M.D. J. Allergy Clin. Immunol. 87 (1991) 621-625
15. Spangfort M.D., and Larsen J.N. Immunol. Allergy Clin. N. Am. 26 (2006) pp. 191-206, v-vi.
16. Slater J.E. In: Lockey R.F.B.S., and Bousquet J. (Eds). Allergens and Allergen Imunotherapy (2004), Marcel Dekker Inc., New York 421-432
17. Larsen J.N., Houghton C.G., Lombardero M., and Lowenstein H. In: Lockey R.F., Bukantz S.C., and Bousquet J. (Eds). Allergens and Allergen Immunotherapy (2004), Marcel Dekker Inc., New York 433-456
18. Slater J.E., and Pastor R.W. J. Allergy Clin. Immunol. 105 (2000) 468-474
19. Soldatova L.N., Paupore E.J., Burk S.H., Pastor R.W., and Slater J.E. J. Allergy Clin. Immunol. 105 (2000) 482-488
20. Jimeno L., Duffort O., Serrano C., Barber D., and Polo F. Allergy 59 (2004) 995-1001
21. Mueller U., Reisman R., Wypych J., Elliott W., Steger R., Walsh S., et al. J. Allergy Clin. Immunol. 68 (1981) 254-261